Sensulin Board of Directors
Co-Founder and Chairman
Dan currently serves on the University of California San Diego’s Rady School of Management's Advisory Council and the University of Miami's Innovation Corporate Advisory Council. He received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies from Harrow and Ealing Colleges of Higher Education in the United Kingdom.
Dr. Huang Xin
Director and Chairman
Dr. Xin is a Managing Partner of Cowin Venture Capital. He is a former Senior Investment Manager for Omaha Capital China, and a former consultant for Boston Consulting Group. He received his PhD from Johns Hopkins University School of Medicine, and is a graduate of Peking Union Medical College and Peking University.
Co-Founder and CEO
Mr. Moradi is a successful entrepreneur, having founded or been a principal in several Nanotech and biopharma startups. Mike was a co-founder and CEO of an ocular pharmaceutical company and specialty Contract Research Organization (CRO), which was #264 fastest growing private company in the 2009 Inc. 500. He co-founded Southwest Nanotechnologies (“SWeNT”), a world-leading manufacturer of carbon nanotubes, and Nanopolaris (now Unidym), which was acquired in 2011 y a publicly traded South Korean company for $145MM.